Activities
Lab-to-Community Research Program:
- Develop and evaluate biomarkers for early detection of NPC in high-risk populations
- Study risk factors and mechanisms of pathogenesis to develop new ways to prevent NPC
Lab-to-Clinic Research Program:
- Develop and evaluate new biomarkers for disease stratification and prognosis
- Identify new therapeutic targets, repurpose therapeutic agents and develop new therapies for NPC
Technology platforms:
- Establish and utilize cutting edge technologies in genomics, cell-based assays and in vivo pre-clinical technologies
- Establish platform technologies and pipelines to support cancer research
